A blood collection in healthy adults and children aiming to see if apixaban, a new investigational anticoagulant (blood thinner) currently studied in adults, can also be used in children.

Registry ID

EUCTR2014-003963-39

Source registry

EUCTR

Phase

PHASE1

Sponsor

Bristol-Myers Squibb Company

Last update

2026-08-16

Conditions

• Thrombosis

Summary

To characterize the in vitro anti-FXa activity of apixaban in pediatric subjects as compared to adult population using Rotachrom chromageneic anti-Xa assay.

Related clinical trials

• Inpatient Monitoring of Unfractionated Heparin
• Platelet Volunteers, Longitudinal and Multi-omic Study
• ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
• Thromboprophylaxis in Lower Limb Immobilisation
• Association of Anti-factor Xa Activity With Venous Thromboembolism in Critically Ill Patients
• Personalizing Thromboprophylaxis for Patients With Peripheral Artery Disease

View on source registry